The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 42 | — | 20.1x | Near average | |
Growth | 40 | -11.7% | 5.6% | Near average | |
Quality | 66 | 162.7% | 7.6% | Near average | |
Safety | 17 | 3.6x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Precision BioSciences, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Precision BioSciences, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
DTIL stock shows a state of complete stability in analyst estimates over the periods (last 1, 7, and 30 days), with the projected target price stabilizing at 19 dollars. Notably, there is an absence of Dispersion among analysts, as the high, low, and average estimates coincide at the same figure, indicating full technical consensus among the three analysts covering the stock, despite the significant gap between the current price (7.23) and the target.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.